Represents first step towards a potential clinical treatment of locally advanced pancreatic cancer LYON, France, January 13, 2022-- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in ...

Research published in The Journal of Urology offers an alternative to invasive prostate cancer treatments like surgery and radiation. Standard treatments can have serious side effects such as urinary ...

For some prostate cancer patients, radical treatment (surgery or radiation) are treatment standards. However, these procedures may cause side effects including urinary incontinence or impotency. A new ...

Salvage robotic-assisted radical prostatectomy (sRARP) for local prostate cancer (PCa) recurrence after high-intensity focused ultrasound partial ablation (HIFU-PA) is relatively safe and provides ...

First Unfold AI ®-Assisted Focal One procedures successfully performed at the UCLA School of Medicine FDA-cleared Unfold AI enables urologists to provide tailored, patient-specific Robotic HIFU ...

In a study, men who underwent high-intensity focused ultrasound partial gland ablation for prostate cancer had excellent preservation of potency and continence. Focal ablation of prostate cancer (PCa) ...

High-intensity focused ultrasound (HIFU) - a technology used to treat localized prostate cancer - has shown adequate control of prostate cancer while avoiding major side effects of surgery or ...

LYON, France, October 1, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, today announced that the first patients have been treated in a Phase I/II study evaluating the ...

TORONTO, July 31, 2017 (GLOBE NEWSWIRE) -- With reference to its press release dated June 30, 2017, Profound Medical Corp. (TSXV:PRN) (OTCQX:PRFMF) (“Profound”) announced today that all closing ...

LYON, France, May 22, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the Centers for Medicare and Medicaid Services (CMS) have ...